RACK1 and non-small cell lung carcinoma: Receptor of activated kinase 1 (RACK1) is overexpressed in non-small cell lung cancer, and the level of RACK1 is clearly associated with the pathological characteristics, such as tumour stage, differentiation and metastasis, of non-small cell lung cancer patients.